ArticleGlobalization and health2025
Investigating the determinants of under-five child mortality in Türkiye: the role of inequality in access to healthcare.
Article in Globalization and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUnder-five mortality remains a key indicator of healthcare effectiveness, yet disparities persist due to inequitable health investments, and human capital development.
aimThis study investigates the long-run determinants of under-five mortality in Türkiye by incorporating health expenditures, human capital, and health equality into a robust econometric framework. A key focus is to examine the extent to which health equality modulates the impact of health expenditures on child mortality and whether an inequitable distribution of healthcare services undermines the mortality-reducing effects of financial investments.
methodThis study employs time-series econometric techniques to analyze secondary data from 1975 to 2022. Stationarity is tested using the ADF and KPSS tests, while the Bayer-Hanck cointegration test assesses long-run equilibrium. The FMOLS method estimates the long-term impact of key variables on under-five mortality, addressing autocorrelation and heteroscedasticity concerns.
resultsThe results indicate that increased health expenditures and greater human capital reduce under-five mortality, and this pattern remains consistent across both model specifications. When health equality is included in the analysis, its influence emerges as the strongest factor in lowering mortality. However, the interaction between health expenditures and health equality shows that the mortality-reducing effect of health expenditures weakens when resources are distributed unfairly. These findings highlight that the effectiveness of financial investments depends heavily on the degree of equity within the health system.
conclusionThis study confirms that health expenditure, human capital development, and equitable resource distribution are key to reducing under-five mortality. However, the results also show that when health expenditures are allocated inequitably, their impact becomes weaker, underscoring the critical role of equality. Policies must therefore prioritize fairness in the distribution of health resources, while future research should continue to examine how health expenditures and human capital can be optimized to improve accessibility and efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.